Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

anna sauerbier; Anna Sauerbier; Johanna Herberg; Vasilija Stopic; Philipp A. Loehrer; Keyoumars Ashkan; Alexandra Rizos; Stefanie T. Jost; Jan Niklas Petry-Schmelzer; Alexandra Gronostay; Christian Schneider; Veerle Visser-Vandewalle; Julian Evans; Christopher Nimsky; Gereon R. Fink; Angelo Antonini; Pablo Martinez-Martin; Monty Silverdale; Daniel Weintraub; Anette Schrag; K. Ray Chaudhuri; Lars Timmermann; Haidar S. Dafsari; Charles Adler; Roongroj Bhidayasiri; Per Borghammer; Paolo Barone; David J. Brooks; Richard Brown; Marc Cantillon; Camille Carroll; Miguel Coelho; Cristian Falup-Pecurariu; Tove Henriksen; Michele Hu; Peter Jenner; Beomseok Jeon; Milica Kramberger; Padma Kumar; Mónica Kurtis; Valentina Leta; Simon Lewis; Irene Litvan; Kelly Lyons; Davide Martino; Mario Masellis; Hideki Mochizuki; James F. Morley; Melissa Nirenberg; Per Odin; Javier Pagonabarraga

doi:10.1038/s41531-024-00701-6

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

anna sauerbier, Anna Sauerbier^*, Johanna Herberg, Vasilija Stopic, Philipp A. Loehrer, Keyoumars Ashkan, Alexandra Rizos, Stefanie T. Jost, Jan Niklas Petry-Schmelzer, Alexandra Gronostay, Christian Schneider, Veerle Visser-Vandewalle, Julian Evans, Christopher Nimsky, Gereon R. Fink, Angelo Antonini, Pablo Martinez-Martin, Monty Silverdale, Daniel Weintraub, Anette SchragK. Ray Chaudhuri, Lars Timmermann, Haidar S. Dafsari^*, Charles Adler, Roongroj Bhidayasiri, Per Borghammer, Paolo Barone, David J. Brooks, Richard Brown, Marc Cantillon, Camille Carroll, Miguel Coelho, Cristian Falup-Pecurariu, Tove Henriksen, Michele Hu, Peter Jenner, Beomseok Jeon, Milica Kramberger, Padma Kumar, Mónica Kurtis, Valentina Leta, Simon Lewis, Irene Litvan, Kelly Lyons, Davide Martino, Mario Masellis, Hideki Mochizuki, James F. Morley, Melissa Nirenberg, Per Odin, Javier Pagonabarraga

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In this prospective, open-label, multicentre study, we assessed patients with anxiety undergoing STN-DBS for PD preoperatively and at 6-month follow-up postoperatively. We assessed the Hospital Anxiety and Depression Scale (HADS-anxiety and depression subscales), Unified PD Rating Scale-motor examination, Scales for Outcomes in PD-motor (SCOPA-M)-activities of daily living (ADL) and -motor complications, Non-Motor Symptom Scale (NMSS), PDQuestionnaire-8 (PDQ-8), and levodopa-equivalent daily dose. We tested changes at follow-up with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We identified patients with a clinically relevant anxiety improvement of anxiety based on a designated threshold of ½ standard deviation of baseline HADS-anxiety. Moreover, we investigated predictors of HADS-anxiety changes with correlations and linear regressions. We included 50 patients with clinically relevant baseline anxiety (i.e., HADS-anxiety ≥ 8) aged 63.1 years ± 8.3 with 10.4 years ± 4.5 PD duration. HADS-anxiety improved significantly at 6-month follow-up as 80% of our cohort experienced clinically relevant anxiety improvement. In predictor analyses, worse baseline SCOPA-ADL and NMSS-urinary domain were associated with greater HADS-anxiety improvements. HADS-anxiety and PDQ-8 changes correlated moderately. Worse preoperative ADL and urinary symptoms predicted favourable postoperative anxiety outcome, which in turn was directly proportionate to greater QoL improvement. This study highlights the importance of detailed anxiety assessments alongside other non-motor and motor symptoms when advising and monitoring patients undergoing STN-DBS for PD.

Original language	English
Article number	114
Journal	npj Parkinson's Disease
Volume	10
Issue number	1
Early online date	16 Sept 2024
DOIs	https://doi.org/10.1038/s41531-024-00701-6
Publication status	Published - Dec 2024

Access to Document

10.1038/s41531-024-00701-6

Cite this

anna sauerbier, Sauerbier, A., Herberg, J., Stopic, V., Loehrer, P. A., Ashkan, K., Rizos, A., Jost, S. T., Petry-Schmelzer, J. N., Gronostay, A., Schneider, C., Visser-Vandewalle, V., Evans, J., Nimsky, C., Fink, G. R., Antonini, A., Martinez-Martin, P., Silverdale, M., Weintraub, D., ... Pagonabarraga, J. (2024). Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease. npj Parkinson's Disease, 10(1), Article 114. https://doi.org/10.1038/s41531-024-00701-6

@article{f751bf49e74f43629381db00857f614b,

title = "Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson{\textquoteright}s disease",

abstract = "The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson{\textquoteright}s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In this prospective, open-label, multicentre study, we assessed patients with anxiety undergoing STN-DBS for PD preoperatively and at 6-month follow-up postoperatively. We assessed the Hospital Anxiety and Depression Scale (HADS-anxiety and depression subscales), Unified PD Rating Scale-motor examination, Scales for Outcomes in PD-motor (SCOPA-M)-activities of daily living (ADL) and -motor complications, Non-Motor Symptom Scale (NMSS), PDQuestionnaire-8 (PDQ-8), and levodopa-equivalent daily dose. We tested changes at follow-up with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We identified patients with a clinically relevant anxiety improvement of anxiety based on a designated threshold of ½ standard deviation of baseline HADS-anxiety. Moreover, we investigated predictors of HADS-anxiety changes with correlations and linear regressions. We included 50 patients with clinically relevant baseline anxiety (i.e., HADS-anxiety ≥ 8) aged 63.1 years ± 8.3 with 10.4 years ± 4.5 PD duration. HADS-anxiety improved significantly at 6-month follow-up as 80% of our cohort experienced clinically relevant anxiety improvement. In predictor analyses, worse baseline SCOPA-ADL and NMSS-urinary domain were associated with greater HADS-anxiety improvements. HADS-anxiety and PDQ-8 changes correlated moderately. Worse preoperative ADL and urinary symptoms predicted favourable postoperative anxiety outcome, which in turn was directly proportionate to greater QoL improvement. This study highlights the importance of detailed anxiety assessments alongside other non-motor and motor symptoms when advising and monitoring patients undergoing STN-DBS for PD.",

author = "{anna sauerbier} and Anna Sauerbier and Johanna Herberg and Vasilija Stopic and Loehrer, {Philipp A.} and Keyoumars Ashkan and Alexandra Rizos and Jost, {Stefanie T.} and Petry-Schmelzer, {Jan Niklas} and Alexandra Gronostay and Christian Schneider and Veerle Visser-Vandewalle and Julian Evans and Christopher Nimsky and Fink, {Gereon R.} and Angelo Antonini and Pablo Martinez-Martin and Monty Silverdale and Daniel Weintraub and Anette Schrag and {Ray Chaudhuri}, K. and Lars Timmermann and Dafsari, {Haidar S.} and Charles Adler and Roongroj Bhidayasiri and Per Borghammer and Paolo Barone and Brooks, {David J.} and Richard Brown and Marc Cantillon and Camille Carroll and Miguel Coelho and Cristian Falup-Pecurariu and Tove Henriksen and Michele Hu and Peter Jenner and Beomseok Jeon and Milica Kramberger and Padma Kumar and M{\'o}nica Kurtis and Valentina Leta and Simon Lewis and Irene Litvan and Kelly Lyons and Davide Martino and Mario Masellis and Hideki Mochizuki and Morley, {James F.} and Melissa Nirenberg and Per Odin and Javier Pagonabarraga",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1038/s41531-024-00701-6",

language = "English",

volume = "10",

journal = "npj Parkinson's Disease",

issn = "2373-8057",

publisher = "Springer Nature",

number = "1",

}

anna sauerbier, Sauerbier, A, Herberg, J, Stopic, V, Loehrer, PA, Ashkan, K, Rizos, A, Jost, ST, Petry-Schmelzer, JN, Gronostay, A, Schneider, C, Visser-Vandewalle, V, Evans, J, Nimsky, C, Fink, GR, Antonini, A, Martinez-Martin, P, Silverdale, M, Weintraub, D, Schrag, A, Ray Chaudhuri, K, Timmermann, L, Dafsari, HS, Adler, C, Bhidayasiri, R, Borghammer, P, Barone, P, Brooks, DJ, Brown, R, Cantillon, M, Carroll, C, Coelho, M, Falup-Pecurariu, C, Henriksen, T, Hu, M, Jenner, P, Jeon, B, Kramberger, M, Kumar, P, Kurtis, M, Leta, V, Lewis, S, Litvan, I, Lyons, K, Martino, D, Masellis, M, Mochizuki, H, Morley, JF, Nirenberg, M, Odin, P & Pagonabarraga, J 2024, 'Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease', npj Parkinson's Disease, vol. 10, no. 1, 114. https://doi.org/10.1038/s41531-024-00701-6

TY - JOUR

T1 - Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

AU - anna sauerbier

AU - Sauerbier, Anna

AU - Herberg, Johanna

AU - Stopic, Vasilija

AU - Loehrer, Philipp A.

AU - Ashkan, Keyoumars

AU - Rizos, Alexandra

AU - Jost, Stefanie T.

AU - Petry-Schmelzer, Jan Niklas

AU - Gronostay, Alexandra

AU - Schneider, Christian

AU - Visser-Vandewalle, Veerle

AU - Evans, Julian

AU - Nimsky, Christopher

AU - Fink, Gereon R.

AU - Antonini, Angelo

AU - Martinez-Martin, Pablo

AU - Silverdale, Monty

AU - Weintraub, Daniel

AU - Schrag, Anette

AU - Ray Chaudhuri, K.

AU - Timmermann, Lars

AU - Dafsari, Haidar S.

AU - Adler, Charles

AU - Bhidayasiri, Roongroj

AU - Borghammer, Per

AU - Barone, Paolo

AU - Brooks, David J.

AU - Brown, Richard

AU - Cantillon, Marc

AU - Carroll, Camille

AU - Coelho, Miguel

AU - Falup-Pecurariu, Cristian

AU - Henriksen, Tove

AU - Hu, Michele

AU - Jenner, Peter

AU - Jeon, Beomseok

AU - Kramberger, Milica

AU - Kumar, Padma

AU - Kurtis, Mónica

AU - Leta, Valentina

AU - Lewis, Simon

AU - Litvan, Irene

AU - Lyons, Kelly

AU - Martino, Davide

AU - Masellis, Mario

AU - Mochizuki, Hideki

AU - Morley, James F.

AU - Nirenberg, Melissa

AU - Odin, Per

AU - Pagonabarraga, Javier

PY - 2024/12

Y1 - 2024/12

N2 - The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In this prospective, open-label, multicentre study, we assessed patients with anxiety undergoing STN-DBS for PD preoperatively and at 6-month follow-up postoperatively. We assessed the Hospital Anxiety and Depression Scale (HADS-anxiety and depression subscales), Unified PD Rating Scale-motor examination, Scales for Outcomes in PD-motor (SCOPA-M)-activities of daily living (ADL) and -motor complications, Non-Motor Symptom Scale (NMSS), PDQuestionnaire-8 (PDQ-8), and levodopa-equivalent daily dose. We tested changes at follow-up with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We identified patients with a clinically relevant anxiety improvement of anxiety based on a designated threshold of ½ standard deviation of baseline HADS-anxiety. Moreover, we investigated predictors of HADS-anxiety changes with correlations and linear regressions. We included 50 patients with clinically relevant baseline anxiety (i.e., HADS-anxiety ≥ 8) aged 63.1 years ± 8.3 with 10.4 years ± 4.5 PD duration. HADS-anxiety improved significantly at 6-month follow-up as 80% of our cohort experienced clinically relevant anxiety improvement. In predictor analyses, worse baseline SCOPA-ADL and NMSS-urinary domain were associated with greater HADS-anxiety improvements. HADS-anxiety and PDQ-8 changes correlated moderately. Worse preoperative ADL and urinary symptoms predicted favourable postoperative anxiety outcome, which in turn was directly proportionate to greater QoL improvement. This study highlights the importance of detailed anxiety assessments alongside other non-motor and motor symptoms when advising and monitoring patients undergoing STN-DBS for PD.

AB - The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In this prospective, open-label, multicentre study, we assessed patients with anxiety undergoing STN-DBS for PD preoperatively and at 6-month follow-up postoperatively. We assessed the Hospital Anxiety and Depression Scale (HADS-anxiety and depression subscales), Unified PD Rating Scale-motor examination, Scales for Outcomes in PD-motor (SCOPA-M)-activities of daily living (ADL) and -motor complications, Non-Motor Symptom Scale (NMSS), PDQuestionnaire-8 (PDQ-8), and levodopa-equivalent daily dose. We tested changes at follow-up with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We identified patients with a clinically relevant anxiety improvement of anxiety based on a designated threshold of ½ standard deviation of baseline HADS-anxiety. Moreover, we investigated predictors of HADS-anxiety changes with correlations and linear regressions. We included 50 patients with clinically relevant baseline anxiety (i.e., HADS-anxiety ≥ 8) aged 63.1 years ± 8.3 with 10.4 years ± 4.5 PD duration. HADS-anxiety improved significantly at 6-month follow-up as 80% of our cohort experienced clinically relevant anxiety improvement. In predictor analyses, worse baseline SCOPA-ADL and NMSS-urinary domain were associated with greater HADS-anxiety improvements. HADS-anxiety and PDQ-8 changes correlated moderately. Worse preoperative ADL and urinary symptoms predicted favourable postoperative anxiety outcome, which in turn was directly proportionate to greater QoL improvement. This study highlights the importance of detailed anxiety assessments alongside other non-motor and motor symptoms when advising and monitoring patients undergoing STN-DBS for PD.

UR - http://www.scopus.com/inward/record.url?scp=85195692254&partnerID=8YFLogxK

U2 - 10.1038/s41531-024-00701-6

DO - 10.1038/s41531-024-00701-6

M3 - Article

AN - SCOPUS:85195692254

SN - 2373-8057

VL - 10

JO - npj Parkinson's Disease

JF - npj Parkinson's Disease

IS - 1

M1 - 114

ER -

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this